IBDEI0YX ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15583,0)
 ;;=R73.01^^88^864^44
 ;;^UTILITY(U,$J,358.3,15583,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15583,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,15583,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,15583,2)
 ;;=^5019561
 ;;^UTILITY(U,$J,358.3,15584,0)
 ;;=R74.8^^88^864^1
 ;;^UTILITY(U,$J,358.3,15584,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15584,1,3,0)
 ;;=3^Abnormal Levels of Serum Enzymes
 ;;^UTILITY(U,$J,358.3,15584,1,4,0)
 ;;=4^R74.8
 ;;^UTILITY(U,$J,358.3,15584,2)
 ;;=^5019566
 ;;^UTILITY(U,$J,358.3,15585,0)
 ;;=R03.0^^88^864^25
 ;;^UTILITY(U,$J,358.3,15585,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15585,1,3,0)
 ;;=3^Elevated BP Reading w/o Diagnosis of HTN
 ;;^UTILITY(U,$J,358.3,15585,1,4,0)
 ;;=4^R03.0
 ;;^UTILITY(U,$J,358.3,15585,2)
 ;;=^5019171
 ;;^UTILITY(U,$J,358.3,15586,0)
 ;;=Z91.19^^88^864^51
 ;;^UTILITY(U,$J,358.3,15586,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15586,1,3,0)
 ;;=3^Noncompliance w/ Medical Treatment/Regimen
 ;;^UTILITY(U,$J,358.3,15586,1,4,0)
 ;;=4^Z91.19
 ;;^UTILITY(U,$J,358.3,15586,2)
 ;;=^5063618
 ;;^UTILITY(U,$J,358.3,15587,0)
 ;;=E66.01^^88^864^52
 ;;^UTILITY(U,$J,358.3,15587,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15587,1,3,0)
 ;;=3^Obesity,Morbid
 ;;^UTILITY(U,$J,358.3,15587,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,15587,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,15588,0)
 ;;=F43.11^^88^864^59
 ;;^UTILITY(U,$J,358.3,15588,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15588,1,3,0)
 ;;=3^PTSD,Acute
 ;;^UTILITY(U,$J,358.3,15588,1,4,0)
 ;;=4^F43.11
 ;;^UTILITY(U,$J,358.3,15588,2)
 ;;=^5003571
 ;;^UTILITY(U,$J,358.3,15589,0)
 ;;=F43.12^^88^864^60
 ;;^UTILITY(U,$J,358.3,15589,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15589,1,3,0)
 ;;=3^PTSD,Chronic
 ;;^UTILITY(U,$J,358.3,15589,1,4,0)
 ;;=4^F43.12
 ;;^UTILITY(U,$J,358.3,15589,2)
 ;;=^5003572
 ;;^UTILITY(U,$J,358.3,15590,0)
 ;;=I25.119^^88^864^5
 ;;^UTILITY(U,$J,358.3,15590,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15590,1,3,0)
 ;;=3^Athscl Hrt Dis of Native Cor Art w/ Ang Pctrs,Unspec
 ;;^UTILITY(U,$J,358.3,15590,1,4,0)
 ;;=4^I25.119
 ;;^UTILITY(U,$J,358.3,15590,2)
 ;;=^5007111
 ;;^UTILITY(U,$J,358.3,15591,0)
 ;;=I25.10^^88^864^6
 ;;^UTILITY(U,$J,358.3,15591,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15591,1,3,0)
 ;;=3^Athscl Hrt Dis of Native Cor Art w/o Ang Pctrs
 ;;^UTILITY(U,$J,358.3,15591,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,15591,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,15592,0)
 ;;=F17.219^^88^864^49
 ;;^UTILITY(U,$J,358.3,15592,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15592,1,3,0)
 ;;=3^Nicotine Dependence,Cigarettes
 ;;^UTILITY(U,$J,358.3,15592,1,4,0)
 ;;=4^F17.219
 ;;^UTILITY(U,$J,358.3,15592,2)
 ;;=^5003369
 ;;^UTILITY(U,$J,358.3,15593,0)
 ;;=Z51.5^^88^864^62
 ;;^UTILITY(U,$J,358.3,15593,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15593,1,3,0)
 ;;=3^Palliative Care Encounter
 ;;^UTILITY(U,$J,358.3,15593,1,4,0)
 ;;=4^Z51.5
 ;;^UTILITY(U,$J,358.3,15593,2)
 ;;=^5063063
 ;;^UTILITY(U,$J,358.3,15594,0)
 ;;=Z23.^^88^864^26
 ;;^UTILITY(U,$J,358.3,15594,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15594,1,3,0)
 ;;=3^Encounter for Immunization(s)
 ;;^UTILITY(U,$J,358.3,15594,1,4,0)
 ;;=4^Z23.
 ;;^UTILITY(U,$J,358.3,15594,2)
 ;;=^5062795
 ;;^UTILITY(U,$J,358.3,15595,0)
 ;;=E11.65^^88^864^18
 ;;^UTILITY(U,$J,358.3,15595,1,0)
 ;;=^358.31IA^4^2
